North East and North Cumbria
ICS Formulary
 
back
8 Malignant disease and immunosuppression
08-01-02 Anthracyclines and other cytotoxic antibiotics

Bleomycin
Formulary
  • Also approved for use in intralesional sclerotherapy in the treatment of low-flow vascular lesions. unlicensedunlicensed indication

Cytotoxic Drug  Red View adult BNF  View SPC online  View childrens BNF
Dactinomycin
Formulary

Cytotoxic Drug  Red View adult BNF  View SPC online  View childrens BNF
Daunorubicin
Formulary
  • The following formualtions are approved:
    • 20mg injection;
    • 10mg, 15mg, 35mg;
    • 40mg prefilled syringes.

Cytotoxic Drug  Red View adult BNF  View SPC online  View childrens BNF
Doxorubicin
Formulary
  • Doxorubicin 50mg injection - includes use with DC Beads for use in transcatheter arterial chemoembolisation (TACE) therapy in patients with hepatocellular cancer. 
  • Doxorubicin 20mg & 50mg pegylated liposomal injection - approved for second-line (or subsequent) treatment in advanced ovarian cancer in line with NICE. 
  • Approved for the treatment of recurrent ovarian cancer in line with NICE.
Link  NICE TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer
Link  MHRA Drug Safety Update (July 2020): Liposomal and lipid- complex formulations: name change to reduce medication errors

Cytotoxic Drug  Red View adult BNF  View SPC online  View childrens BNF
Epirubicin
Formulary
  • Note: epirubicin 100mg injection is unlicensedunlicensed.

Cytotoxic Drug  Red View adult BNF  View SPC online  View childrens BNF
Idarubicin
Formulary
  • Approved formulations include:
    • 5mg and 10mg capsules;
    • 10mg injection.

Cytotoxic Drug  Red View adult BNF  View SPC online  View childrens BNF
Mitomycin
Formulary
  • Also approved for treatment in combination with 5-Fluorouracil for bladder cancer concurrent with radiotherapy.
  • Mitomycin 0.04% preservative free eye drops  are also approved for use - unlicensedunlicensed.

Cytotoxic Drug  Red View adult BNF  View SPC online  View childrens BNF
Mitoxantrone
Formulary

Cytotoxic Drug  Red View adult BNF  View SPC online  View childrens BNF
Pixantrone
Formulary
  • Approved as a possible treatment for adults with multiply relapsed or refractory aggressive non-Hodgkin's B cell lymphoma if they have previously been treated with rituximab and they are having third- or fourth-line treatment in line with NICE. 
Link  NICE TA306: Pixantrone monotherapy

Cytotoxic Drug  Red View adult BNF  View SPC online  View childrens BNF